Get the Stockscreener App
1.155
5.00%
0.055
After Hours:
1.11
-0.045
-3.90%
Ironwood Pharmaceuticals Inc stock is traded at $1.155, with a volume of 858.38K.
It is up +5.00% in the last 24 hours and up +43.55% over the past month.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
See More
Previous Close:
$1.10
Open:
$1.07
24h Volume:
858.38K
Relative Volume:
0.48
Market Cap:
$187.61M
Revenue:
$400.57M
Net Income/Loss:
$9.21M
P/E Ratio:
28.88
EPS:
0.04
Net Cash Flow:
$146.36M
1W Performance:
-12.50%
1M Performance:
+43.55%
6M Performance:
-25.00%
1Y Performance:
-75.21%
1-Day Range:
$1.07
$1.16
1-Week Range:
$1.01
$1.3488
52-Week Range:
$0.5271
$5.1288
Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile
Name
Ironwood Pharmaceuticals Inc
Sector
Phone
617-621-7722
Address
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Compare IRWD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRWD
Ironwood Pharmaceuticals Inc
|
1.155 | 178.68M | 400.57M | 9.21M | 146.36M | 0.04 |
|
ZTS
Zoetis Inc
|
153.32 | 67.90B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.40 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.80 | 44.04B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.95 | 21.20B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
400.52 | 17.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-15-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-14-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Sep-09-24 | Initiated | Leerink Partners | Market Perform |
| Aug-08-24 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Jan-17-24 | Initiated | Craig Hallum | Buy |
| Dec-14-23 | Initiated | Wells Fargo | Overweight |
| Nov-09-23 | Initiated | Jefferies | Buy |
| Sep-28-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-02-22 | Initiated | CapitalOne | Overweight |
| Apr-22-22 | Initiated | Piper Sandler | Overweight |
| Sep-30-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jun-17-20 | Initiated | Northland Capital | Outperform |
| Jul-10-19 | Resumed | Credit Suisse | Neutral |
| Mar-27-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-25-19 | Upgrade | H.C. Wainwright | Sell → Neutral |
| Jan-24-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Nov-07-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Nov-07-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Jul-23-18 | Initiated | H.C. Wainwright | Sell |
| May-09-18 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-05-18 | Downgrade | BofA/Merrill | Buy → Underperform |
| Dec-06-17 | Downgrade | Mizuho | Buy → Neutral |
| Jul-21-17 | Downgrade | JP Morgan | Overweight → Neutral |
| May-03-17 | Initiated | Wells Fargo | Outperform |
| Apr-07-17 | Reiterated | Mizuho | Buy |
| Feb-22-17 | Reiterated | Barclays | Equal Weight |
| Nov-04-16 | Reiterated | Mizuho | Buy |
| Oct-24-16 | Reiterated | Wedbush | Neutral |
| Oct-10-16 | Reiterated | Mizuho | Buy |
| Sep-27-16 | Reiterated | WallachBeth | Hold |
View All
Ironwood Pharmaceuticals Inc Stock (IRWD) Latest News
What are Ironwood Pharmaceuticals Inc.’s recent SEC filings showingJuly 2025 Technicals & Technical Entry and Exit Tips - خودرو بانک
Is Ironwood Pharmaceuticals Inc. likely to announce a buybackJuly 2025 Gainers & AI Powered Market Entry Strategies - خودرو بانک
Is Ironwood Pharmaceuticals Inc. stock a good pick for beginnersJuly 2025 Sector Moves & Intraday High Probability Setup Alerts - خودرو بانک
When is the best time to exit Ironwood Pharmaceuticals Inc.Weekly Investment Summary & Risk Adjusted Buy/Sell Alerts - Newser
Comparing Ironwood Pharmaceuticals Inc. in custom built stock radarsQuarterly Trade Report & Safe Entry Zone Tips - Newser
Using Ichimoku Cloud for Ironwood Pharmaceuticals Inc. technicalsMarket Sentiment Report & Daily Momentum Trading Reports - Newser
Combining price and volume data for Ironwood Pharmaceuticals Inc.2025 Trading Recap & Daily Stock Trend Reports - Newser
Measuring Ironwood Pharmaceuticals Inc.’s beta against major indicesMarket Activity Report & Safe Entry Momentum Tips - Newser
Can Ironwood Pharmaceuticals Inc. recover in the next quarter2025 Price Targets & Long Hold Capital Preservation Tips - Newser
How hedge fund analytics apply to Ironwood Pharmaceuticals Inc. stock2025 Key Lessons & Weekly Top Gainers Trade List - Newser
Why Did Ironwood Pharmaceuticals Stock Plunge 17.74%? - AInvest
Is Ironwood Pharmaceuticals Inc. reversing from oversold territoryJuly 2025 Outlook & Fast Entry and Exit Trade Plans - Newser
Earnings visualization tools for Ironwood Pharmaceuticals Inc.Watch List & Stepwise Entry and Exit Trade Signals - Newser
Is Ironwood Pharmaceuticals Inc.’s growth already priced inWeekly Stock Report & Safe Entry Momentum Tips - خودرو بانک
Should you hold or exit Ironwood Pharmaceuticals Inc. now2025 Breakouts & Breakdowns & Weekly Market Pulse Updates - Newser
Ironwood Pharma Regains Nasdaq Compliance - TipRanks
Will Ironwood Pharmaceuticals Inc. benefit from rate cutsJuly 2025 Update & Free Risk Controlled Daily Trade Plans - خودرو بانک
Ironwood Pharmaceuticals Inc. stock trendline breakdownQuarterly Profit Report & Long-Term Investment Growth Plans - Newser
Published on: 2025-09-03 06:20:24 - Newser
Published on: 2025-09-03 04:31:42 - Newser
Ironwood Pharmaceuticals Inc. stock chart pattern explainedEarnings Summary Report & Risk Managed Investment Signals - Newser
Is Ironwood Pharmaceuticals Inc. stock entering bullish territoryMarket Sentiment Review & Weekly Hot Stock Watchlists - Newser
Will Ironwood Pharmaceuticals Inc. stock recover after recent drop2025 Winners & Losers & Risk Managed Investment Strategies - Newser
Published on: 2025-09-02 07:32:33 - خودرو بانک
Using data models to predict Ironwood Pharmaceuticals Inc. stock movementWeekly Profit Analysis & Technical Confirmation Alerts - Newser
What indicators show strength in Ironwood Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Safe Entry Zone Tips - Newser
What Fibonacci levels say about Ironwood Pharmaceuticals Inc. reboundExit Point & AI Driven Price Predictions - Newser
Published on: 2025-08-31 13:49:26 - beatles.ru
RSI Reset May Fuel Rebound in Ironwood Pharmaceuticals Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Risk adjusted return profile for Ironwood Pharmaceuticals Inc. analyzedPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser
Options Data Show Bullish Bias in Ironwood Pharmaceuticals Inc.July 2025 Rallies & Safe Entry Trade Reports - beatles.ru
Analysts Spot Bullish Divergence in Ironwood Pharmaceuticals Inc.2025 Stock Rankings & Safe Capital Preservation Plans - beatles.ru
Analyzing drawdowns of Ironwood Pharmaceuticals Inc. with statistical toolsInsider Buying & Low Risk Entry Point Guides - Newser
Published on: 2025-08-29 17:20:59 - Newser
Ironwood Pharmaceuticals Inc Stock (IRWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):